Position in CELC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$139,620,093
-$13,979,814 QoQ
Shares Held
1,334,545
-0.8% QoQ
Ownership
2.73%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,237,057 across 522 Biotechnology names. CELC ranks #22 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CELC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $139,620,093 | 1,334,545 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $153,599,907 | 1,345,715 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $139,533,265 | 1,398,970 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $74,734,887 | 1,512,852 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $10,467,453 | 784,079 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,461,540 | 836,948 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,478,500 | 876,891 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $20,765,229 | 1,392,705 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $46,444,914 | 2,835,465 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $50,745,850 | 2,349,345 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $31,983,756 | 2,195,179 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $17,985,471 | 1,967,776 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $17,497,507 | 1,593,580 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,576,257 | 1,324,513 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,296,691 | 1,091,841 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,399,853 | 1,035,842 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,401,705 | 263,924 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $181,024 | 19,361 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $171,019 | 12,966 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $208,602 | 11,589 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $137,520 | 5,730 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $97,440 | 6,795 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $37,464 | 4,090 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $48,082 | 8,290 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $45,834 | 6,614 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,214 | 1,110 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||